Notification
No new Notification messages
Enviro Infra Engineers IPO is Open!
Apply for the Enviro Infra Engineers IPO through UPI in just minutes.
Q2 FY'24-25 Results of Top Companies
Reliance, TCS, HDFC Bank & more: Explore key financial highlights from India's top quarterly results.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
akums drugs and pharmaceutical stock

Akums Drugs and Pharmaceutical Share Price

640.1 30.44 (4.99%)
Nov 22 2024 03:30 PM Pharmaceuticals NSE: AKUMS

Akums Drugs and Pharmaceutical Share Price Update

As of the latest trading session, Akums Drugs and Pharmaceutical share price is currently at 640.1, which is up by 30.44 from its previous closing. Today, the stock has fluctuated between 640.10 and 640.10. Over the past year, Akums Drugs and Pharmaceutical has achieved a return of 0.00 %. In the last month alone, the return has been -33.42 %. Read More...

Akums Drugs and Pharmaceutical Performance

Day Range

Low640.10 High640.10
640.10

52 Week Range

Low 530.05 High 1175.90
640.10

Akums Drugs and Pharmaceutical Share Price

24715

544222

AKUMS

img img img img
No Data Available

Open Price

640.10

Prev. Close

609.65

Volume (Shares)

35476.00

Total traded value

227.08

Upper Circuit

640.10

Lower Circuit

579.20

Note: The current prices & values are delayed, Login to your account for live updates.

Akums Drugs and Pharmaceutical Fundamentals


(Standalone)

Market Cap (Cr) 9157.54
PE Ratio (TTM) 150.60
Book Value / Share 142.04
Beta 0.98
ROE 91.28%
EPS (TTM) 4.12
Dividend Yield 0.00%
Net Profit Qtr (Cr) 50.37

Akums Drugs and Pharmaceutical Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars SEP 2024 (Values in Cr)
Revenue 328.35
Operating Expense 298.85
Net Profit 50.37
Net Profit Margin (%) 15.34
Earnings Per Share (EPS) 3.38
EBITDA 75.19
Effective Tax Rate (%) 18.25
Particulars JUN 2024 (Values in Cr)
Revenue 317.28
Operating Expense 289.18
Net Profit 41.88
Net Profit Margin (%) 13.19
Earnings Per Share (EPS) 2.93
EBITDA 69.86
Effective Tax Rate (%) 22.84
Particulars MAR 2024 (Values in Cr)
Revenue 298.35
Operating Expense 372.77
Net Profit -57.87
Net Profit Margin (%) -19.39
Earnings Per Share (EPS) -4.04
EBITDA -35.15
Effective Tax Rate (%) -18.00
Particulars SEP 2023 (Values in Cr)
Revenue 447.00
Operating Expense 370.09
Net Profit 52.75
Net Profit Margin (%) 11.80
Earnings Per Share (EPS) 3.69
EBITDA 93.38
Effective Tax Rate (%) 34.85
Particulars JUN 2023 (Values in Cr)
Revenue 315.61
Operating Expense 514.34
Net Profit -189.67
Net Profit Margin (%) -60.09
Earnings Per Share (EPS) -13.26
EBITDA -166.75
Effective Tax Rate (%) -6.36
Particulars MAR 2024 (Values in Cr)
Revenue 1444.12
Operating Expense 1621.78
Net Profit -165.45
Net Profit Margin (%) -11.45
Earnings Per Share (EPS) -11.56
EBITDA -51.93
Effective Tax Rate (%) -60.74
Particulars MAR 2023 (Values in Cr)
Revenue 1286.83
Operating Expense 1088.13
Net Profit 125.43
Net Profit Margin (%) 9.74
Earnings Per Share (EPS) 8.77
EBITDA 193.50
Effective Tax Rate (%) 16.55
Particulars MAR 2022 (Values in Cr)
Revenue 1162.06
Operating Expense 1555.51
Net Profit -381.78
Net Profit Margin (%) -32.85
Earnings Per Share (EPS) -53.33
EBITDA -303.57
Effective Tax Rate (%) -13.97
Particulars MAR 2021 (Values in Cr)
Revenue 837.44
Operating Expense 837.66
Net Profit -145.43
Net Profit Margin (%) -17.36
Earnings Per Share (EPS) -20.33
EBITDA -168.28
Effective Tax Rate (%) 25.49
Particulars MAR 2024 (Values in Cr)
Book Value / Share 49.59
ROE % -3.57
ROCE % 1.24
Total Debt to Total Equity 0.83
EBITDA Margin 3.76
Particulars MAR 2023 (Values in Cr)
Book Value / Share 50.13
ROE % 19.46
ROCE % 11.73
Total Debt to Total Equity 0.76
EBITDA Margin 10.32
Particulars MAR 2022 (Values in Cr)
Book Value / Share 86.95
ROE % -33.30
ROCE % -9.43
Total Debt to Total Equity 0.33
EBITDA Margin -2.23
Particulars MAR 2021 (Values in Cr)
Book Value / Share 6801.28
ROE % 15.36
ROCE % 11.63
Total Debt to Total Equity 0.17
EBITDA Margin 9.14
Particulars MAR 2020 (Values in Cr)
Book Value / Share 5554.41
ROE % 6.04
ROCE % 9.29
Total Debt to Total Equity 0.24
EBITDA Margin 8.30
Particulars MAR 2023 (Values in Cr)
Book Value / Share 21.77
ROE % 91.28
ROCE % 20.84
Total Debt to Total Equity 0.66
EBITDA Margin 25.91
Particulars MAR 2022 (Values in Cr)
Book Value / Share 25.94
ROE % -101.46
ROCE % -25.83
Total Debt to Total Equity 0.22
EBITDA Margin -26.12
Particulars MAR 2021 (Values in Cr)
Book Value / Share 4358.55
ROE % 17.25
ROCE % 4.52
Total Debt to Total Equity 0.05
EBITDA Margin 9.70
Particulars MAR 2020 (Values in Cr)
Book Value / Share 5476.91
ROE % 6.55
ROCE % 7.36
Total Debt to Total Equity 0.06
EBITDA Margin 14.31
Particulars MAR 2019 (Values in Cr)
Book Value / Share 7164.46
ROE % 9.30
ROCE % 13.27
Total Debt to Total Equity 0.05
EBITDA Margin 20.28
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 277.05
Total Assets 3516.36
Total Liabilities 3516.36
Total Equity 720.48
Share Outstanding 143064350
Price to Book Ratio 0.00
Return on Assets (%) -0.11
Return on Capital (%) -0.33
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 149.98
Total Assets 3266.52
Total Liabilities 3266.52
Total Equity 723.37
Share Outstanding 143064350
Price to Book Ratio 0.00
Return on Assets (%) 2.90
Return on Capital (%) 7.53
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 102.84
Total Assets 3069.04
Total Liabilities 3069.04
Total Equity 625.17
Share Outstanding 71532175
Price to Book Ratio 0.00
Return on Assets (%) -8.22
Return on Capital (%) -25.69
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 67.86
Total Assets 2192.01
Total Liabilities 2192.01
Total Equity 887.13
Share Outstanding 1300585
Price to Book Ratio 0.00
Return on Assets (%) 5.63
Return on Capital (%) 12.67
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 147.36
Total Assets 2078.27
Total Liabilities 2078.27
Total Equity 720.88
Share Outstanding 1300585
Price to Book Ratio 0.00
Return on Assets (%) 2.10
Return on Capital (%) 5.07
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 8.84
Total Assets 1894.20
Total Liabilities 1894.20
Total Equity 311.50
Share Outstanding 143064350
Price to Book Ratio 0.00
Return on Assets (%) 6.62
Return on Capital (%) 27.44
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 25.73
Total Assets 1813.94
Total Liabilities 1813.94
Total Equity 185.53
Share Outstanding 71532175
Price to Book Ratio 0.00
Return on Assets (%) -21.04
Return on Capital (%) -124.1
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.99
Total Assets 1298.35
Total Liabilities 1298.35
Total Equity 567.04
Share Outstanding 1300585
Price to Book Ratio 0.00
Return on Assets (%) -11.20
Return on Capital (%) -24.66
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 72.47
Total Assets 1426.26
Total Liabilities 1426.26
Total Equity 712.31
Share Outstanding 1300585
Price to Book Ratio 0.00
Return on Assets (%) 3.56
Return on Capital (%) 6.8
Particulars MAR 2024 (Values in Cr)
Net Income -45.27
Cash from Operations 560.67
Cash from Investing -330.41
Cash from Financing -108.02
Net change in Cash 59.82
Free Cash Flow 872.08
Particulars MAR 2023 (Values in Cr)
Net Income 150.29
Cash from Operations 273.69
Cash from Investing -304.70
Cash from Financing 124.54
Net change in Cash -3.53
Free Cash Flow 602.48
Particulars MAR 2022 (Values in Cr)
Net Income -193.19
Cash from Operations 86.67
Cash from Investing -234.82
Cash from Financing 236.04
Net change in Cash 33.07
Free Cash Flow 344.25
Particulars MAR 2021 (Values in Cr)
Net Income 172.26
Cash from Operations 180.43
Cash from Investing -109.38
Cash from Financing -95.22
Net change in Cash -69.72
Free Cash Flow 263.24
Particulars MAR 2020 (Values in Cr)
Net Income 113.82
Cash from Operations 76.85
Cash from Investing -189.86
Cash from Financing 233.01
Net change in Cash 71.28
Free Cash Flow 138.91
Particulars MAR 2023 (Values in Cr)
Net Income 150.31
Cash from Operations 124.31
Cash from Investing -202.16
Cash from Financing 89.90
Net change in Cash -18.25
Free Cash Flow 240.57
Particulars MAR 2022 (Values in Cr)
Net Income -334.97
Cash from Operations 235.50
Cash from Investing -297.95
Cash from Financing 94.98
Net change in Cash 25.34
Free Cash Flow 265.79
Particulars MAR 2021 (Values in Cr)
Net Income -195.19
Cash from Operations -242.91
Cash from Investing -99.96
Cash from Financing 2.59
Net change in Cash -41.78
Free Cash Flow -209.83
Particulars MAR 2020 (Values in Cr)
Net Income 75.85
Cash from Operations 22.37
Cash from Investing -241.71
Cash from Financing 301.53
Net change in Cash 38.06
Free Cash Flow 53.83
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 54.37 31.25 2.96 416.66 37.54 / 77.70
BLISS GVS PHARMA LTD 129.00 16.15 1.34 1358.40 92.25 / 148.95
CIPLA LTD 1465.65 25.64 4.17 118365.23 1165.10 / 1702.00
FERMENTA BIOTECH LIMITED 326.85 113.49 3.31 961.95 145.00 / 354.60
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 54.37 47.28 9.24 416.66 37.54 / 77.70
AMRUTAJAN HEALTH LTD 706.05 42.95 6.85 2041.24 556.05 / 861.40
ASTRAZENECA PHARMA IND LT 6288.90 122.14 23.14 15722.25 4050.15 / 8139.85
BLISS GVS PHARMA LTD 129.00 16.80 1.32 1358.40 92.25 / 148.95

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 597.10
  • 26 Days 750.50
  • 10 Days 655.40
  • 50 Days 799.00
  • 12 Days 674.60
  • 100 Days 819.30
  • 20 Days 731.70
  • 200 Days 800.20
609.65
PIVOT
First Resistance 609.65
Second Resistance 609.65
Third Resistance 609.65
First Support 609.65
Second Support 609.65
Third Support 609.65
RSI 16.23
MACD -75.95
Commodity Channel Index (CCI) -102.11
ADX 50.16
Williams % R -78.63

Over 1 Month

down

-33.42

Over 3 Months

down

-39.68

Over 6 Months

down

-23.43

Over 1 Year

down

0.00

Over 3 Years

down

0.00

Over 5 Years

down

0.00

Akums Drugs and Pharmaceutical Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

Akums Drugs and Pharmaceutical Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
12.22
Promoter Holdings
75.26
FII
7.34
DII
5.17
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Akums Master Trust Shareholding of Promoter and Promoter Group 6.42E7 40.79
Sandeep Jain Shareholding of Promoter and Promoter Group 2.712769E7 17.24
Sanjeev Jain Shareholding of Promoter and Promoter Group 2.711394E7 17.23
Ruby Qc Investment Holdings Pte Ltd Public Shareholding 7278535.0 4.62
Smallcap World Fund, Inc Public Shareholding 3390630.0 2.15
Franklin India Smaller Companies Fund Public Shareholding 2698731.0 1.71
Lata Jain Shareholding of Promoter and Promoter Group 13750.0 0.01
Manan Jain Shareholding of Promoter and Promoter Group 0.0 0.0
Kanishk Jain Shareholding of Promoter and Promoter Group 0.0 0.0
Umang Jain Shareholding of Promoter and Promoter Group 0.0 0.0
Arushi Jain Shareholding of Promoter and Promoter Group 0.0 0.0
Shivangi Jain Shareholding of Promoter and Promoter Group 0.0 0.0
Rajiv Mittal Shareholding of Promoter and Promoter Group 0.0 0.0
Rajesh Sharma Shareholding of Promoter and Promoter Group 0.0 0.0
Kusum Jain Shareholding of Promoter and Promoter Group 0.0 0.0
Kiran Jain Shareholding of Promoter and Promoter Group 0.0 0.0
Archana Jain Shareholding of Promoter and Promoter Group 0.0 0.0
Anuradha Pal Shareholding of Promoter and Promoter Group 0.0 0.0
Anita Jain Shareholding of Promoter and Promoter Group 0.0 0.0
Sudha Jain Shareholding of Promoter and Promoter Group 0.0 0.0
Neerja Gupta Shareholding of Promoter and Promoter Group 0.0 0.0
May & Baker Pharmaceuticals Limited Shareholding of Promoter and Promoter Group 0.0 0.0
Hygosap Pharma Private Limited (formerly Known As Burroughs Welcome Pharmacia Private Limited) Shareholding of Promoter and Promoter Group 0.0 0.0
Amazing Research & Laboratories Limited Shareholding of Promoter and Promoter Group 0.0 0.0
Welcure Pharmaceuticals Private Limited Shareholding of Promoter and Promoter Group 0.0 0.0
Parke Davis Healthcare Limited Shareholding of Promoter and Promoter Group 0.0 0.0
Dhanwantri Vedaresearch Llp Shareholding of Promoter and Promoter Group 0.0 0.0
Delcure Lifesciences Limited Shareholding of Promoter and Promoter Group 0.0 0.0
Avha Lifesciences Private Limited Shareholding of Promoter and Promoter Group 0.0 0.0
American Remedies Lifesciences Limited Shareholding of Promoter and Promoter Group 0.0 0.0
Akums Foundation Shareholding of Promoter and Promoter Group 0.0 0.0
Akum Impex Llp Shareholding of Promoter and Promoter Group 0.0 0.0
Akome Lifecare Private Limited Shareholding of Promoter and Promoter Group 0.0 0.0
Sandeep Jain Trust Shareholding of Promoter and Promoter Group 0.0 0.0
Ausl Trust Shareholding of Promoter and Promoter Group 0.0 0.0

Akums Drugs and Pharmaceutical

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About Akums Drugs and Pharmaceutical

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by Akums Drugs and Pharmaceutical

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Akums Drugs & Pharmaceuticals Ltd?

Answer Field

The share price of Akums Drugs & Pharmaceuticals Ltd for NSE is ₹ 640.1 and for BSE is ₹ 640.4.

What is the Market Cap of Akums Drugs & Pharmaceuticals Ltd?

Answer Field

The market cap of Akums Drugs & Pharmaceuticals Ltd for NSE is ₹ 91,57.54 Cr. and for BSE is ₹ 91,61.84 Cr. as of now.

What is the 52 Week High and Low of Akums Drugs & Pharmaceuticals Ltd?

Answer Field

The 52 Week High and Low of Akums Drugs & Pharmaceuticals Ltd for NSE is ₹ 1175.90 and ₹ 530.05 and for BSE is ₹ 1174.85 and ₹ 527.00.

How to Buy Akums Drugs & Pharmaceuticals Ltd share?

Answer Field

You can trade in Akums Drugs & Pharmaceuticals Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Akums Drugs & Pharmaceuticals Ltd?

Answer Field

The 1 year returns on the stock has been 0.00%.

What is the Current Share Price of Akums Drugs & Pharmaceuticals Ltd?

Answer Field

Akums Drugs & Pharmaceuticals Ltd share price is for NSE ₹ 640.1 & for BSE ₹ 640.4 as on Nov 22 2024 03:30 PM.

What is the Market Cap of Akums Drugs & Pharmaceuticals Ltd Share?

Answer Field

The market cap of Akums Drugs & Pharmaceuticals Ltd for NSE ₹ 91,57.54 & for BSE ₹ 91,61.84 as on Nov 22 2024 03:30 PM.

What is the P/E Ratio of Akums Drugs & Pharmaceuticals Ltd Share?

Answer Field

As on Nov 22 2024 03:30 PM the price-to-earnings (PE) ratio for Akums Drugs & Pharmaceuticals Ltd share is 150.60.

What is the PB ratio of Akums Drugs & Pharmaceuticals Ltd Share?

Answer Field

As on Nov 22 2024 03:30 PM, the price-to-book (PB) ratio for Akums Drugs & Pharmaceuticals Ltd share is 142.04.

How to Buy Akums Drugs & Pharmaceuticals Ltd Share?

Answer Field

You can trade in Akums Drugs & Pharmaceuticals Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Akums Drugs & Pharmaceuticals Ltd Share on Bajaj Broking App?

Answer Field

To buy Akums Drugs & Pharmaceuticals Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Akums Drugs & Pharmaceuticals Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs + Users

icon-with-text

4.8+ App Rating

icon-with-text

4 Languages

icon-with-text

₹5000+ Cr MTF Book

icon-with-text
loader